-
1321
Immunogenic dying cells elicit potent anti-tumor T cell immunity against lung metastasis and tumorigenesis
Published 2025-01-01“…In this study, we investigated the efficacy of immunotherapy via the immunogenic cell death (ICD) dying tumor cells in mouse models of lung metastasis and tumorigenesis. …”
Get full text
Article -
1322
Exploring the Impact of the Multimodal CAPABLE eHealth Intervention on Health-Related Quality of Life in Patients With Melanoma Undergoing Immune-Checkpoint Inhibition: Prospective...
Published 2025-01-01“… Abstract BackgroundPatients with melanoma receiving immunotherapy with immune-checkpoint inhibitors often experience immune-related adverse events, cancer-related fatigue, and emotional distress, affecting health-related quality of life () and clinical outcome to immunotherapy. eHealth tools can aid patients with cancer in addressing issues, such as adverse events and psychosocial well-being, from various perspectives. …”
Get full text
Article -
1323
-
1324
Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches
Published 2025-03-01“…Microneedles (MNs) are a prospective system in cancer immunotherapy to overcome barriers regarding proper antigen delivery and presentation. …”
Get full text
Article -
1325
-
1326
Rationale and design of a multicentre randomised controlled trial on circulating tumour DNA-guided neoadjuvant treatment strategy for locally advanced rectal cancer (CINTS-R)
Published 2025-02-01“…New strategies such as total neoadjuvant therapy (TNT) and neoadjuvant immunotherapy have shown great promise in certain patient populations. …”
Get full text
Article -
1327
Multi‑omics identification of a novel signature for serous ovarian carcinoma in the context of 3P medicine and based on twelve programmed cell death patterns: a multi-cohort machin...
Published 2025-01-01“…Conclusions The CDI-based model, which was established using 14 PCD-related genes, accurately predicted the tumor microenvironment, immunotherapy response, and drug sensitivity of patients with SOC. …”
Get full text
Article -
1328
Influence of Organ‐Specific Extranodal Involvement on Survival Outcomes in Stage IV Diffuse Large B‐Cell Lymphoma
Published 2025-01-01“…Methods We retrospectively reviewed data from 119 patients with DLBCL aged < 60 years who achieved CR after chemo‐immunotherapy between 2008 and 2020. Patient survival rates were analyzed in correlation with different extranodal sites using univariate and multivariate models. …”
Get full text
Article -
1329
Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement
Published 2011-01-01“…Following allogeneic stem cell transplantation, awareness for atypical manifestations of granulocytic sarcoma appears prudent, the cellular immunotherapy should aim at immunological disease control.…”
Get full text
Article -
1330
Identification of disulfidptosis-related subtypes in gastric cancer and GAMT is a key gene during disulfidptosis
Published 2025-01-01“…Cluster 2 patients are more sensitive to various chemotherapy drugs and immunotherapy. Mesenchymal cells, especially myCAF, endothelial cells, and smooth muscle cells, have strong disulfidptosis scores. …”
Get full text
Article -
1331
Metastatic Malignant Melanoma of the Inguinal Lymph Node with Unknown Primary Lesion
Published 2015-01-01“…Work up could not detect the primary lesion and patient was started on radiotherapy and immunotherapy. Conclusion. We present a case of malignant melanoma of unknown primary presenting in an unusual place which is the inguinal lymph node. …”
Get full text
Article -
1332
Fluorescence-Guided Resection of Malignant Glioma with 5-ALA
Published 2016-01-01“…In the future, chemotherapy with new anticancer agents, immunotherapy, and new methods of radiotherapy and gene therapy will be developed; however, ALA will play a key role in malignant glioma treatment before the development of these new treatments. …”
Get full text
Article -
1333
Targeting glycolysis: exploring a new frontier in glioblastoma therapy
Published 2025-01-01“…Future research will aim to address these challenges by improving drug delivery, minimizing side effects, and exploring combination therapies with radiotherapy, chemotherapy, and immunotherapy to develop more precise and effective personalized treatment strategies for GBM.…”
Get full text
Article -
1334
The overview of modern approaches in treatment of triple negative breast cancer
Published 2020-03-01“…The review highlights the possibilities of modern targeted drugs-PARP inhibitors, chk1 inhibitors UCN‑01, immunotherapy possibilities for the treatment of this aggressive subtype of breast cancer.…”
Get full text
Article -
1335
Central Precocious Puberty as a Complication of Therapy with Adrenocorticotropin (ACTH) and an Aromatase Inhibitor for Refractory Nephrotic Syndrome
Published 2019-01-01“…We report a 6 8/12-year-old girl with recurrent proteinuria, resistant to standard immunotherapy. She underwent related renal transplant but again developed proteinuria and was started on ACTH. …”
Get full text
Article -
1336
Potential of Black Phosphorus in Immune-Based Therapeutic Strategies
Published 2022-01-01“…In conclusion, BP shows promise in natural antitumor biological activity, biological imaging, drug delivery, PTT/PDT/SDT/PAT/PIT, nanovaccines, nanoadjuvants, and combination immunotherapy regimens.…”
Get full text
Article -
1337
Protein Kinases and Their Inhibitors in Pluripotent Stem Cell Fate Regulation
Published 2019-01-01Get full text
Article -
1338
Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis
Published 2017-01-01“…This review summarizes the main aspects related with the biology of IFNs, mainly associated with TB, as well as presents the main applications of these cytokines related to prophylaxis, diagnosis, and immunotherapy of TB.…”
Get full text
Article -
1339
Recognition and Treatment of BCG Failure in Bladder Cancer
Published 2011-01-01“…In this setting, treatment options are limited and include repeat BCG treatment, an alternate immunotherapy regimen, chemotherapy, or device-assisted therapy. …”
Get full text
Article -
1340
Granulomatous dermatitis post Mycobacterium Indicus Pranii (MIP) vaccine in severe covid-19 infection: an exaggerated hypersensitivity phenomenon
Published 2024-01-01“…Mycobacterium indicus pranii (MIP) vaccine is widely used in dermatology as immunotherapy for warts as well as in patients with leprosy. …”
Get full text
Article